期刊文献+

环孢素A-pH敏感性纳米粒的制备工艺和体外释药特性 被引量:5

Study on preparation and releasing characteristics of Cyclosporin A pH sensitive nanoparticles in vitro
下载PDF
导出
摘要 目的:研究环孢素A-pH敏感性纳米粒的制备方法和体外释药特性。方法:采用乳化-溶剂扩散技术结合正交实验设计制备了环孢素A-pH敏感性纳米粒;超速离心法测定纳米粒的包封率,并对其粒径、表面形态、体外释药和稳定性影响因素进行考察。结果:环孢素A-pH敏感性纳米粒的包封率为99.7%;平均粒径为44.8 nm;透射电镜下呈均匀规则的圆球型;体外释放实验中,当pH>6时,药物能迅速的释放出来。结论:pH敏感性纳米粒有望开发成为一种新型环孢素A纳米制剂。 Objective:To study the preparation and releasing characteristics of cyclosporine A-Eudragit S100-Nanoparticles (CyA-NP) in vitro. Methods:Ethanol-injection technique and orthogonal experimental design was introduced to prepare CyA-NP. The encapsulation efficiency was determined by separating nanoparticles from dispersed aqueous medium by ultracentrifugation. The particle size,superficial appearance and drug release profile of CyA-NP in vitro were measured while the stability was investigated. Results:The particles exhibited satisfied mean particle size of 44.8 nm with the encapsulation efficiency over 99.7%. The load-drug nanoparticles was spherical observed by the transmission electric microscope (TEM). The drug released from nanoparticles was burst when the medium pH was above 6.0. Conclusion:pH-sensitive Eudragit S100 was a potential drug vehicle for developing a high performance CyA nanoparticle carrier system.
机构地区 苏州大学药学院
出处 《中国新药杂志》 CAS CSCD 北大核心 2008年第20期1783-1786,共4页 Chinese Journal of New Drugs
基金 江苏省科技厅社会发展项目资助(BS200522) 江苏省高校高新技术产业发展项目资助(JHB05-46) 江苏省卫生厅招标课题(H200630)
关键词 环孢素A pH敏感性纳米粒 体外释放 Cyclosporine A pH-sensitive nanoparticals releasing in vitro
  • 相关文献

参考文献8

二级参考文献19

  • 1赵应征,鲁翠涛,梅兴国.常用多指标综合评价法在优选实验中的应用[J].医学研究生学报,2004,17(7):624-626. 被引量:35
  • 2吴传斌,何素梅,高文伟,魏树礼.阿霉素磁性明胶微球的制备及特性研究[J].中国医药工业杂志,1994,25(2):63-66. 被引量:15
  • 3Lindholm A, Henricsson S, Lind M, et al. Intraindividual variability in the relative availability of cyclosporin after oral dosing [ J ] . Eur J Clin Pharmacol,1988,34 (5) :461 - 464.
  • 4Tjai JF, Webber IR, Back DJ. Cyclosporin metabolism by the gastrointestinal mucosa [ J ]. Br J Clin Pharmacol,1991,31(3) :344 -346.
  • 5Noble S, Markham A. Cyclosporin: a review of pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation(Neoral) [J]. Drugs, 1995,50(5):924-941.
  • 6Luke DR, Kasiske BL, Matzke GR, et al. Effect of cyclosporin on the isolated perfused rat kidney [ J ].Transplantation, 1987,43:795-799.
  • 7Cavanak T, Sucker H. Cyclosporin. Formulation of dosage forms [J]. Prog Allergy, 1986,38:65 -72.
  • 8Kawashima Y, Niwa T, Handa T, et al. Preparation of controlled-release microspheres of ibuprofen with acrylic polymers by a novel quasi-emulsion solvent diffusion method [J]. J Pharm Sci, 1989,78( 1 ) :68 -72.
  • 9Malmary MF, Houti I, Labat C, et al.Chronopharmacokinetics of cyclosporine A following a single iv dose in the Wistar rat [ J ]. Eur J Pharm Sci,1995,3( 1 ) :49 -56.
  • 10McClean S, Prosser E, Meehan E, et al. Binding and uptake of biodegradable polydl- lactide micro- and nanoparticles in intestinal epithelia [ J ]. Eur J Pharm Sci, 1998,6(2) :153 - 163.

共引文献23

同被引文献32

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部